Lv31
242 积分 2026-01-24 加入
Letter: probing the consequences of potent acid inhibition by vonoprazan – authors’ reply
30天前
已完结
Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments
1个月前
已完结
Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication
1个月前
已完结
Changes in gastric morphology during long-term use of vonoprazan compared to proton pump inhibitors
1个月前
已完结
Vonoprazan as a Long-term Maintenance Treatment for Erosive Esophagitis: VISION, a 5-Year, Randomized, Open-label Study
1个月前
已完结
Efficacy and Cost-Effectiveness of Vonoprazan–Amoxicillin Dual Therapy Versus Esomeprazole–Bismuth Quadruple Therapy for Helicobacter pylori: A Propensity Score-Matched Study
1个月前
已完结
Keverprazan Hydrochloride: First Approval
1个月前
已完结
The efficacy of keverprazan-based quadruple therapy for Helicobacter pylori eradication: A phase III, randomised, double-blind, multicentre trial
1个月前
已完结
Real-world evidence on the efficacy and safety of vonoprazan-amoxicillin dual therapy for Helicobacter pylori treatment in elderly patients
1个月前
已完结
Real-world evidence on the efficacy and safety of vonoprazan-amoxicillin dual therapy for Helicobacter pylori treatment in elderly patients
1个月前
已完结
皖公网安备34019202002308
